• 1.

    Singh AK, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355:20852098. doi: 10.1056/NEJMoa065485

  • 2.

    Drüeke TB, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:20712084. doi: 10.1056/NEJMoa062276

  • 3.

    Pfeffer MA, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361:20192032. doi: 10.1056/NEJMoa0907845

  • 4.

    Chertow GM, et al. Vadadustat in patients with anemia and non-dialysis-dependent CKD. N Engl J Med 2021; 384:15891600. doi: 10.1056/NEJMoa2035938

  • 5.

    Chen N, et al. Roxadustat for anemia in patients with kidney disease not receiving dialysis. N Engl J Med 2019; 381:10011010. doi: 10.1056/NEJMoa1813599

  • 6.

    Coyne DW, et al. Roxadustat for CKD-related anemia in non-dialysis patients. Kidney Int Rep 2020; 6:624635. doi: 10.1016/j.ekir.2020.11.034

  • 7.

    Fishbane S, et al. Roxadustat for treating anemia in patients with CKD not on dialysis: Results from a randomized phase 3 study. J Am Soc Nephrol 2021; 32:737755. doi: 10.1681/ASN.2020081150

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Provenzano R, et al. Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. Nephrol Dial Transplant 2021; 36:17171730. doi: 10.1093/ndt/gfab051

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Eckardt KU, et al. Safety and efficacy of vadadustat for anemia in patients undergoing dialysis. N Engl J Med 2021; 384:16011612. doi: 10.1056/NEJMoa2025956

New Era in Treatment of Anemia in Chronic Kidney Disease?

Arash Rashidi Arash Rashidi, MD, is with the Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Search for other papers by Arash Rashidi in
Current site
Google Scholar
PubMed
Close
Restricted access
Save